Related Experiment Video
Updated: Jan 14, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Incidence and risk factors for low serum albumin concentrations in neonates evaluated for jaundice
Napat Rojsirikulchai1, Suchanun Keesukphan2, Kanuengnit Emrat3
1Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Abstract:
ObjectiveTo examine the incidence and risk factors for low serum albumin concentrations in neonates evaluated for jaundice.MethodsA retrospective chart review was conducted on inborn neonates who were born at ≥35 weeks gestation and evaluated for jaundice at 3 university hospitals in Thailand from 1 January to 31 December 2023. The neonates' demographics, neurotoxicity risk factors, serum albumin concentrations, and maternal characteristics were analyzed. The neonates were classified into the hypoalbuminemia (<3.0 g/dL) and normal albumin (≥3.0 g/dL) groups. Univariate and multivariate regression analyses were used to identify the factors associated with hypoalbuminemia.ResultsAmong 902 neonates who had jaundice evaluation, 229 (25.4%) had serum albumin <3.0 g/dL. The hypoalbuminemia group had a lower gestational age and Apgar scores, a higher prevalence of male sex, and clinical instability or sepsis compared with the normal albumin group. Neonates in the hypoalbuminemia group were also younger at testing and their mothers were older than those in the normal albumin group. In the univariate analysis, male sex, clinical instability or sepsis, low gestational age, low birth weight, low Apgar scores, and increased maternal age were associated with hypoalbuminemia (p < 0.1). In the multivariate analysis, lower gestational age, male sex, and clinical instability or sepsis remained significant risk factors for hypoalbuminemia (all p < 0.05).ConclusionsAbout one-quarter of neonates evaluated for jaundice had serum albumin <3.0 g/dL. Lower gestational age, male sex, and clinical instability or sepsis were significant risk factors, suggesting that targeted albumin screening in these high-risk groups may be warranted.
More Related Videos
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Distribution: Plasma Protein Binding
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption